NERV
Price
$2.40
Change
+$0.13 (+5.73%)
Updated
Sep 3 closing price
Capitalization
16.78M
67 days until earnings call
TCRX
Price
$1.87
Change
+$0.12 (+6.86%)
Updated
Sep 3 closing price
Capitalization
106.12M
62 days until earnings call
Interact to see
Advertisement

NERV vs TCRX

Header iconNERV vs TCRX Comparison
Open Charts NERV vs TCRXBanner chart's image
Minerva Neurosciences
Price$2.40
Change+$0.13 (+5.73%)
Volume$1.56K
Capitalization16.78M
TScan Therapeutics
Price$1.87
Change+$0.12 (+6.86%)
Volume$278.61K
Capitalization106.12M
NERV vs TCRX Comparison Chart in %
Loading...
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NERV vs. TCRX commentary
Sep 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NERV is a Buy and TCRX is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 04, 2025
Stock price -- (NERV: $2.27 vs. TCRX: $1.75)
Brand notoriety: NERV and TCRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NERV: 62% vs. TCRX: 59%
Market capitalization -- NERV: $16.78M vs. TCRX: $106.12M
NERV [@Biotechnology] is valued at $16.78M. TCRX’s [@Biotechnology] market capitalization is $106.12M. The market cap for tickers in the [@Biotechnology] industry ranges from $101.69B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NERV’s FA Score shows that 0 FA rating(s) are green whileTCRX’s FA Score has 1 green FA rating(s).

  • NERV’s FA Score: 0 green, 5 red.
  • TCRX’s FA Score: 1 green, 4 red.
According to our system of comparison, NERV is a better buy in the long-term than TCRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NERV’s TA Score shows that 6 TA indicator(s) are bullish while TCRX’s TA Score has 4 bullish TA indicator(s).

  • NERV’s TA Score: 6 bullish, 5 bearish.
  • TCRX’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, NERV is a better buy in the short-term than TCRX.

Price Growth

NERV (@Biotechnology) experienced а -3.71% price change this week, while TCRX (@Biotechnology) price change was -7.41% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.32%. For the same industry, the average monthly price growth was +16.10%, and the average quarterly price growth was +32.67%.

Reported Earning Dates

NERV is expected to report earnings on Nov 10, 2025.

TCRX is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+0.32% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TCRX($106M) has a higher market cap than NERV($16.8M). NERV YTD gains are higher at: 1.954 vs. TCRX (-42.434). NERV has higher annual earnings (EBITDA): 11.2M vs. TCRX (-130.55M). TCRX has more cash in the bank: 218M vs. NERV (15.2M). NERV has less debt than TCRX: NERV (0) vs TCRX (96.7M). TCRX has higher revenues than NERV: TCRX (6.96M) vs NERV (0).
NERVTCRXNERV / TCRX
Capitalization16.8M106M16%
EBITDA11.2M-130.55M-9%
Gain YTD1.954-42.434-5%
P/E Ratio1.62N/A-
Revenue06.96M-
Total Cash15.2M218M7%
Total Debt096.7M-
FUNDAMENTALS RATINGS
NERV: Fundamental Ratings
NERV
OUTLOOK RATING
1..100
28
VALUATION
overvalued / fair valued / undervalued
1..100
34
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
39
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
43

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
NERVTCRX
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
89%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 10 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
87%
Aroon
ODDS (%)
Bullish Trend 2 days ago
86%
Bullish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
NERV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TCRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ANPCY0.900.05
+5.71%
ANGLE plc
BKQNF4.14N/A
N/A
Bank of Queensland Ltd.
GBEI0.05N/A
N/A
Great Basin Energies, Inc.
MCCK45.00-1.00
-2.17%
Mestek, Inc.
AMIGY48.58-1.49
-2.99%
Admiral Group Plc.

NERV and

Correlation & Price change

A.I.dvisor indicates that over the last year, NERV has been loosely correlated with ASPHF. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NERV jumps, then ASPHF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NERV
1D Price
Change %
NERV100%
-4.03%
ASPHF - NERV
44%
Loosely correlated
N/A
DNLI - NERV
35%
Loosely correlated
+1.18%
ANAB - NERV
33%
Loosely correlated
+1.38%
TCRX - NERV
32%
Poorly correlated
-2.78%
GBIO - NERV
32%
Poorly correlated
-0.33%
More

TCRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, TCRX has been loosely correlated with MGNX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if TCRX jumps, then MGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TCRX
1D Price
Change %
TCRX100%
-2.78%
MGNX - TCRX
47%
Loosely correlated
-1.69%
FATE - TCRX
45%
Loosely correlated
-0.96%
ABOS - TCRX
42%
Loosely correlated
N/A
CRBU - TCRX
41%
Loosely correlated
+0.53%
IMNM - TCRX
40%
Loosely correlated
-2.42%
More